School of Pharmaceutical Sciences, and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, and Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education) , Tsinghua University , Beijing , China.
Pharmaceutical Development and Manufacture Science, Janssen Research & Development , Johnson & Johnson , Shanghai , China.
Mol Pharm. 2018 Oct 1;15(10):4643-4653. doi: 10.1021/acs.molpharmaceut.8b00633. Epub 2018 Aug 28.
Hydroxypropyl methylcellulose acetate succinate (HPMC-AS) is one of the commonly selected polymers used in amorphous solid dispersions (ASD) with excellent capabilities to maintain aqueous supersaturation of poorly water-soluble drugs and inhibit their crystallization, but the underlying mechanisms remain elusive. In this study, posaconazole was chosen as the model drug to study the supersaturation maintaining and crystallization inhibition capabilities of different types of HPMC-AS under pH 5.5-7.5. We analyzed the HPMC-AS aggregation status in solution using combination of static and dynamic light scattering and observed higher polymer aggregation number when higher grade HPMC-AS or lower pH was used, which correlates well with prolonged drug supersaturation or crystallization inhibition. The amount of HPMC-AS coprecipitated with PSZ, a direct indicator of drug/HPMC-AS affinity, also showed positive correlation with the drug supersaturation and crystallization inhibition in the dissolution process. Therefore, we conclude that the aggregation behavior of HPMC-AS and the drug/HPMC-AS affinity are the key mechanisms that lead to posaconazole supersaturation and crystallization inhibition when HPMC-AS was applied.
羟丙甲纤维素醋酸琥珀酸酯(HPMC-AS)是在无定形固体分散体(ASD)中常用的聚合物之一,具有维持低水溶性药物水相过饱和状态和抑制其结晶的优异能力,但潜在机制仍不清楚。在这项研究中,泊沙康唑被选为模型药物,以研究不同类型的 HPMC-AS 在 pH5.5-7.5 下维持过饱和度和抑制结晶的能力。我们使用静态和动态光散射相结合的方法分析了溶液中 HPMC-AS 的聚集状态,并观察到使用更高等级的 HPMC-AS 或更低的 pH 时,聚合物的聚集数更高,这与延长药物过饱和度或抑制结晶的时间很好地相关。HPMC-AS 与 PSZ 共沉淀的量(药物/HPMC-AS 亲和力的直接指标)也与药物在溶解过程中的过饱和度和结晶抑制呈正相关。因此,我们得出结论,当 HPMC-AS 被应用时,HPMC-AS 的聚集行为和药物/HPMC-AS 的亲和力是导致泊沙康唑过饱和度和结晶抑制的关键机制。